Ulcer healing · ulceration caused by nerve damage in leprosy
It is very uncertain whether topical ketanserin (2%) changes primary outcome: healing of ulcers (healing of ulcer at 3 months) compared with clioquinol cream (3%) or zinc paste (very low certainty).
1 finding from 1 review
Primary outcome: adverse events (assessed at 3 months as minimum, moderate or severe) · ulceration caused by nerve damage in leprosy
1 finding from 1 review
Secondary outcome: quality of life · ulceration caused by nerve damage in leprosy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Secondary outcome: acceptability of treatment · ulceration caused by nerve damage in leprosy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cost of the intervention · ulceration caused by nerve damage in leprosy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical failure · Children with extensive decay involving the dental pulp in primary teeth
Mineral trioxide aggregate (MTA) may leads to lower clinical failure compared with 3Mix (ciprofloxacin + metronidazole + minocycline) (low certainty).
1 finding from 1 review
Radiological failure · Children with extensive decay involving the dental pulp in primary teeth
Vitapex (calcium hydroxide/iodoform) showed no clear difference in radiological failure compared with 3Mix (ciprofloxacin + metronidazole + minocycline); GRADE not reported.
1 finding from 1 review
Clinical failure · Children with extensive decay involving the dental pulp in primary teeth
Vitapex (calcium hydroxide/iodoform) showed no clear difference in clinical failure compared with 3Mix (ciprofloxacin + metronidazole + minocycline); GRADE not reported.
1 finding from 1 review
Time from arrival to clinical assessment and treatment · patients with minor injuries and illnesses
It is very uncertain whether primary care professionals changes time from arrival to clinical assessment and treatment compared with ordinary emergency department physicians (very low certainty).
1 finding from 1 review
Healthcare use: length of stay in the emergency department · patients with minor injuries and illnesses
It is very uncertain whether primary care professionals changes total length of ED stay compared with ordinary emergency department physicians (very low certainty).
1 finding from 1 review
Hospital admissions · patients with minor injuries and illnesses
It is very uncertain whether primary care professionals changes admission to hospital compared with ordinary emergency department physicians (very low certainty).
1 finding from 1 review
Diagnostic tests · patients with minor injuries and illnesses
It is very uncertain whether primary care professionals changes diagnostic tests compared with ordinary emergency department physicians (very low certainty).
1 finding from 1 review
Treatments given · patients with minor injuries and illnesses
It is very uncertain whether primary care professionals changes treatments given compared with ordinary emergency department physicians (very low certainty).
1 finding from 1 review
Consultations or referrals to hospital‐based specialists · patients with minor injuries and illnesses
It is very uncertain whether primary care professionals changes consultations or referrals to hospital‐based specialists compared with ordinary emergency department physicians (very low certainty).
1 finding from 1 review
Costs · patients with minor injuries and illnesses
1 finding from 1 review
Adverse events · patients with minor injuries and illnesses
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular mortality · people with critical limb ischaemia
The review found no eligible studies for this question.
1 finding from 1 review
Amputation · people with critical limb ischaemia
The review found no eligible studies for this question.
1 finding from 1 review
Quality of life · people with critical limb ischaemia
The review found no eligible studies for this question.
1 finding from 1 review
Adverse events (participants) · people with critical limb ischaemia
PGE1 showed no clear difference in adverse events (participants) compared with inositol niacinate (low certainty).
1 finding from 1 review